Burke & Herbert Financial Services (BHRB) EVP exercises 12,709 stock rights
Rhea-AI Filing Summary
Burke & Herbert Financial Services Corp. executive Robert S. Tissue, EVP Financial Strategy, reported multiple equity transactions in Common Stock on July 17, 2026. He exercised stock-settled appreciation rights for 12,709 shares of Common Stock at exercise prices of $51.58 and $47.47 per share. As payment of exercise price or tax liability, 9,777 shares of Common Stock were delivered at $72.85 per share. Reported holdings include 53,858 Common shares held directly and 373 shares held indirectly by his spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,932 shares
Net Buy
6 txns
Insider
TISSUE ROBERT S
Role
EVP, Financial Strategy
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Settled Appreciation Rights | 8,599 | $0.00 | $0.00 |
| Exercise | Stock Settled Appreciation Rights | 4,110 | $0.00 | $0.00 |
| Exercise | Common Stock | 8,599 | $47.47 | $408K |
| Exercise | Common Stock | 4,110 | $51.58 | $212K |
| Exercise Price or Tax Liability | Common Stock | 9,777 | $72.85 | $712K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Settled Appreciation Rights — 0 shares (Direct);
Common Stock — 53,858 shares (Direct);
Common Stock — 373 shares (Indirect, By Spouse)
Key Figures
Common shares from rights exercise: 12,709 shares
Shares delivered for taxes: 9,777 shares
Direct Common Stock holdings: 53,858 shares
+3 more
6 metrics
Common shares from rights exercise
12,709 shares
Total Common Stock received from exercising Stock Settled Appreciation Rights on July 17, 2026
Shares delivered for taxes
9,777 shares
Common Stock delivered as payment of exercise price or tax liability at $72.85 per share
Direct Common Stock holdings
53,858 shares
Common Stock held directly by Robert S. Tissue as reported in the filing
Indirect spouse holdings
373 shares
Common Stock held indirectly by spouse, reported as indirect ownership
Exercise prices of SSARs
$51.58 and $47.47 per share
Exercise prices for Stock Settled Appreciation Rights converted into Common Stock
SSAR grant sizes
4,110 and 8,599 rights
Stock Settled Appreciation Rights exercised into equal numbers of Common shares
Key Terms
Stock Settled Appreciation Rights, tax-withholding disposition, indirect ownership, derivative security
4 terms
Stock Settled Appreciation Rights financial
"Security title listed as Stock Settled Appreciation Rights"
tax-withholding disposition financial
"Transaction action described as tax-withholding disposition"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
indirect ownership financial
"Ownership type reported as indirect with nature of ownership By Spouse"
derivative security financial
"Transaction type identified as derivative for appreciation rights"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did BHRB executive Robert S. Tissue report?
Robert S. Tissue reported exercising 12,709 Stock Settled Appreciation Rights into Common Stock and a related tax-withholding disposition of 9,777 shares at $72.85 per share, along with updated direct and indirect share holdings.
What were the exercise prices of Robert S. Tissue’s BHRB Stock Settled Appreciation Rights?
The Stock Settled Appreciation Rights were exercised at $51.58 and $47.47 per share, each grant converting into an equal number of BHRB Common shares on July 17, 2026 as reported.
Were Robert S. Tissue’s BHRB transactions under a Rule 10b5-1 trading plan?
The Rule 10b5-1 checkbox in the filing was not marked as an adopted trading plan, indicating these transactions were not affirmatively reported as executed pursuant to a Rule 10b5-1 arrangement.